remifentanil 1 mg powder for concentrate for solution for injection or infusion
fresenius kabi deutschland gmbh - remifentanil - powder for concentrate for solution for injection/infusion - 1 milligram(s) - opioid anesthetics; remifentanil
remifentanil 2 mg powder for concentrate for solution for injection or infusion
fresenius kabi deutschland gmbh - remifentanil - powder for concentrate for solution for injection/infusion - 2 milligram(s) - opioid anesthetics; remifentanil
remifentanil 5 mg powder for concentrate for solution for injection or infusion
fresenius kabi deutschland gmbh - remifentanil - powder for concentrate for solution for injection/infusion - 5 milligram(s) - opioid anesthetics; remifentanil
remifentanil bioavenir 1 mg
bioavenir ltd, israel - remifentanil as hydrochloride - powder for solution for injection - remifentanil as hydrochloride 1 mg - remifentanil - remifentanil bioavenir is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil bioavenir is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.
remifentanil bioavenir 2 mg
bioavenir ltd, israel - remifentanil as hydrochloride - powder for solution for injection - remifentanil as hydrochloride 2 mg/vial - remifentanil - remifentanil bioavenir is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil bioavenir is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.
remifentanil bioavenir 5 mg
bioavenir ltd, israel - remifentanil as hydrochloride - powder for solution for injection - remifentanil as hydrochloride 5 mg - remifentanil - remifentanil bioavenir is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil bioavenir is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.
remifentanil hydrochloride injection, powder, lyophilized, for solution remifentanil hydrochloride- remifentanil hydrochloride
fresenius kabi usa, llc - remifentanil hydrochloride (unii: 5v444h5wic) (remifentanil - unii:p10582jyyk) - remifentanil 1 mg in 1 ml - remifentanil hydrochloride (hcl) for injection is indicated for intravenous (iv) administration: - as an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures. - for continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting. - as an analgesic component of monitored anesthesia care in adult patients. remifentanil hcl is contraindicated: - for epidural or intrathecal administration due to the presence of glycine in the formulation [see nonclinical toxicology (13)] . - in patients with hypersensitivity to remifentanil (e.g., anaphylaxis) [see adverse reactions (6.2)] . risk summary prolonged use of opioid analgesics during pregnancy may cause neonatal opioid withdrawal syndrome. available data with remifentanil hydrochloride in pregnant women are insufficient to
remifentanil-aft, remifentanil (as hydrochloride) 2 mg, powder for injection, glass vial
aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 2.194 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.
remifentanil-aft, remifentanil (as hydrochloride) 5 mg, powder for injection, glass vial
aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 5.485 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.
remifentanil-aft, remifentanil (as hydrochloride) 1 mg, powder for injection, glass vial
aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 1.097 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.